Generex says ruling will allow it to provide Generex Oral-lyn to some patients before approval

September 30th, 2009 Treating mild diabetes during pregnancy beneficialNEW YORK — Treating even mild diabetes that develops during pregnancy helps keep moms and babies from gaining too much weight and makes for easier deliveries, new research shows. Pregnant women in the U.S.

September 28th, 2009 WASHINGTON - An inflammatory molecule called TNF-a may contribute to delayed bone fracture healing in diabetics, according to a study. A research article on the study, published in the American Journal of Pathology, describes diabetes as a condition where the body either does not produce enough, or respond to, insulin.

September 25th, 2009 WASHINGTON - A drug commonly used to treat type 2 diabetes can help fight lethal complications accompanying cancer, say researchers.esearchers from Ohio State University have found that drug rosiglitazone can help combat muscle wasting and severe fat loss among cancer patients. The syndrome called cachexia is responsible for between one-fifth and one-third of all cancer deaths.

September 25th, 2009 NEW DELHI - Delhi Chief Minister Shiela Dikshit Friday launched a web portal giving "complete information" on constraints of and treatment for diabetes. The site - www.ddrc.in - was launched by the Delhi Diabetic Research Centre (DDRC) following a study undertaken by the centre on diabetes and its link to depression.

September 24th, 2009 WASHINGTON - An Indian-origin expert at the University of Colorado Denver has shed light on why an inhaled insulin product turned out to be a commercial failure. Dr. Satish K. Garg, a professor of Medicine and Pediatrics at the University of Colorado Denver, says that the results of a 2-year Phase 3 trial conducted in 385 patients suggest that AIR inhaled insulin was inferior to SC insulin in its ability to maintain optimal blood glucose levels over time, based on measurements of glycosylated hemoglobin (HbA1c).

September 23rd, 2009 WASHINGTON - A combination of exercise counselling by physical therapists and fitness centre training can prove very helpful in improving muscular strength and exercise capacity in people with type 2 diabetes, suggest the findings of a randomised clinical trial. Published in the scientific journal of the American Physical Therapy Association (APTA), a report on the findings highlights the fact that type 2 diabetes often leads to numerous health complications, including a decline in muscular strength and exercise capacity.

September 22nd, 2009 WASHINGTON - Pancreatic fat levels may help predict diabetes, say scientists at UT Southwestern Medical Center who are the first in the U.S. to use an imaging technique called magnetic resonance spectroscopy (MRS) to measure the amount of pancreatic fat in humans.

September 22nd, 2009 SYDNEY - Blood sugar control can cut down the risk of heart disease and stroke among diabetic patients by 15 percent, an analysis based on four studies said. It said that diabetic patients without a history of heart disease derive greater benefits compared to those who have already experienced heart complications.

September 18th, 2009 WASHINGTON - Scientists at University of California, San Diego have identified certain insulin-regulating genes that can also alter the timing of the body clock. They said that the findings can lead to new approaches to treating disorders such as metabolic syndrome that can result, at least in part, from chronic disruption of the sleep-wake cycle.

September 17th, 2009 NEW DELHI - The treatment of Type 2 diabetic patients, especially those who are obese, is full of challenges. According to Dr.

September 15th, 2009 WASHINGTON - A popular diabetes drug called metformin has been found to be effective in fighting breast cancer. The findings of the study from Harvard Medical School showed that metformin, along with conventional chemotherapy, shows promise for treating and delaying recurrence of breast cancer.

September 11th, 2009 BANGALORE - India's biotech major Biocon Friday entered into a strategic tie-up with the US-based Amylin Pharmaceuticals to jointly produce a peptide hybrid molecule for treating diabetes. As part of the tie-up, the two firms will collaborate to develop the therapeutic compound and share the development costs, Biocon said in a statement here.

September 11th, 2009 BANGALORE/ CALIFORNIA - Biocon, Limited (NSE: BIOCON) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes.

September 7th, 2009 LONDON - An international team of researchers have discovered a new gene that appears to affect how insulin works. The new discovery could lead to better treatment of type 2 diabetes, and provide deeper insight into how this widespread disease develops.

August 31st, 2009 SYDNEY - An Indian researcher has found that the flavour-potent chilli could wallop diabetes and cardiovascular disease which are the leading cause of mortality in developed countries. University of Tasmania School of Human Life Sciences research fellow Kiran Ahuja said it was possible that one day chillies would replace aspirin, or be combined with aspirin as a medication for the prevention and treatment of cardiovascular disease.